In Vitro Activities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species

Lignende værker

• In Vitro and In Vivo Characterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile
  af: Mascio, Carmela T. M., et al.
  Udgivet: (2012)
• Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens
  af: Snydman, D. R., et al.
  Udgivet: (2012)
• In Vitro Activity of Ceftazidime-NXL104 against 396 Strains of β-Lactamase-Producing Anaerobes
  af: Citron, Diane M., et al.
  Udgivet: (2011)
• Comparative In Vitro Activities of LFF571 against Clostridium difficile and 630 Other Intestinal Strains of Aerobic and Anaerobic Bacteria
  af: Citron, Diane M., et al.
  Udgivet: (2012)
• Ceftaroline versus Isolates from Animal Bite Wounds: Comparative In Vitro Activities against 243 Isolates, Including 156 Pasteurella Species Isolates
  af: Goldstein, Ellie J. C., et al.
  Udgivet: (2012)